Catalyst Funds Management Pty LTD Pmv Pharmaceuticals, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 2,100 shares of PMVP stock, worth $3,465. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,100Holding current value
$3,465% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PMVP
# of Institutions
83Shares Held
42.3MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.7 Million0.23% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.65MShares$6.02 Million0.08% of portfolio
-
Sio Capital Management, LLC New York, NY3.21MShares$5.3 Million2.53% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.34 Million0.43% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.87 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $75.3M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...